Were you on the conf call yesterday? You should have been so you could ask your very pointed questions. However, it was suggested on the call that the GNBT uplisting can't be done until the shareholder equity is at least +$5M, which may happen in the next 30-60 days. That doesn't mean they can uplist at that time though. That being said, if GNBT were to announce they are going to uplist on a certain day in the future (say 90 days from now), then the stock could certainly move to over $4 with anticipation of institutional purchasing in the future. The say reason when the a stock is going to be added to the S&P 500 that their stock goes up with the anticipation that funds will need to buy proportionately.
Think of it this way, the weather forecast says it might rain hard 7 days from now. Can you guarantee you need an umbrella 7 days from now? Maybe the weather pattern changes and you need that umbrella 4 days from now, or maybe 10 days from now.
Think of it this way, the weather forecast says it might rain hard 7 days from now. Can you guarantee you need an umbrella 7 days from now? Maybe the weather pattern changes and you need that umbrella 4 days from now, or maybe 10 days from now.
Quote:Maybe I misunderstood but was under the impression GNBT had set a very near term objective to go on nasdaq. Its shares will need to trade $4.
As the current price is 1.80, are you suggesting it will rise over $4 in the coming months and not require a reverse split?
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
